Biotechnology in the United States

Biotechnology in the United States


  • Products Id :- OHMF4150
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotechnology in the United States

Summary

Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the United States biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The US biotechnology industry had total revenues of USD 179.0bn in 2017, representing a compound annual growth rate (CAGR) of 14.4% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 105.4bn, equivalent to 58.9% of the industry's overall value.

- The US made up over 47% of global revenues in 2017, making it by far the largest industry in the world.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts

Reasons to buy

- What was the size of the United States biotechnology market by value in 2017?

- What will be the size of the United States biotechnology market in 2022?

- What factors are affecting the strength of competition in the United States biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the United States's biotechnology market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 17

Threat of substitutes 19

Degree of rivalry 20

Leading Companies 21

Amgen, Inc. 21

Baxter International Inc. 24

Biogen, Inc. 27

Merck & Co., Inc. 30

Macroeconomic Indicators 33

Country data 33

Methodology 35

Industry associations 36

Related MarketLine research 36

Appendix 37

About MarketLine 37

List of Figures

Figure 1: United States biotechnology industry value: USD billion, 2013-17

Figure 2: United States biotechnology industry category segmentation: % share, by value, 2017

Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: United States biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in the United States, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2017

Figure 11: Amgen, Inc.: revenues & profitability

Figure 12: Amgen, Inc.: assets & liabilities

Figure 13: Baxter International Inc.: revenues & profitability

Figure 14: Baxter International Inc.: assets & liabilities

Figure 15: Biogen, Inc.: revenues & profitability

Figure 16: Biogen, Inc.: assets & liabilities

Figure 17: Merck & Co., Inc.: revenues & profitability

Figure 18: Merck & Co., Inc.: assets & liabilities

List of Tables

Table 1: United States biotechnology industry value: USD billion, 2013-17

Table 2: United States biotechnology industry category segmentation: USD billion, 2017

Table 3: United States biotechnology industry geography segmentation: USD billion, 2017

Table 4: United States biotechnology industry value forecast: USD billion, 2017-22

Table 5: Amgen, Inc.: key facts

Table 6: Amgen, Inc.: key financials (USD )

Table 7: Amgen, Inc.: key financial ratios

Table 8: Baxter International Inc.: key facts

Table 9: Baxter International Inc.: key financials (USD )

Table 10: Baxter International Inc.: key financial ratios

Table 11: Biogen, Inc.: key facts

Table 12: Biogen, Inc.: key financials (USD )

Table 13: Biogen, Inc.: key financial ratios

Table 14: Merck & Co., Inc.: key facts

Table 15: Merck & Co., Inc.: key financials (USD )

Table 16: Merck & Co., Inc.: key financial ratios

Table 17: United States size of population (million), 2013-17

Table 18: United States gdp (constant 2005 prices, USD billion), 2013-17

Table 19: United States gdp (current prices, USD billion), 2013-17

Table 20: United States inflation, 2013-17

Table 21: United States consumer price index (absolute), 2013-17

Table 22: United States exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24500
Site License
USD 700 INR 49000
Corporate User License
USD 1050 INR 73500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com